Back
Fossil Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
32
FOSL
Fossil Group
Last Price:
0.81
Seasonality Move:
3.85%
Sell
23
AKRO
Akero Therapeutics
Last Price:
20.13
Seasonality Move:
16.15%
Sell
32
Fossil Group (FOSL)
is a Sell
Is Fossil Group a Buy, Sell or Hold?
- The current Fossil Group [FOSL] share price is $0.78. The Score for FOSL is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- FOSL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $19.89. The Score for AKRO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOSL Stock Price Chart
What is Fossil Group's stock price today?
-
The Fossil Group share price today is $0.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOSL is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $19.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
FOSL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 36.31 | Sell |
| Chaikin Money Flow: | 133373 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 0.98) | Sell |
| Bollinger Bands (100): | (0.89 - 1.33) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.31 | Sell |
| Relative Strength Index (14 RSI): | 35.53 | Sell |
| Chaikin Money Flow: | 67074 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.33 - 23.69) | Sell |
| Bollinger Bands (100): | (20.19 - 26.05) | Sell |
FOSL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.81 | Sell |
| 20-day SMA: | 0.87 | Sell |
| 50-day SMA: | 0.93 | Sell |
| 200-day SMA: | 1.51 | Sell |
| 8-day EMA: | 0.8 | Sell |
| 20-day EMA: | 0.85 | Sell |
| 50-day EMA: | 0.94 | Sell |
| 200-day EMA: | 1.62 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.12 | Sell |
| 20-day SMA: | 21.44 | Sell |
| 50-day SMA: | 24.52 | Sell |
| 200-day SMA: | 28.56 | Sell |
| 8-day EMA: | 20.16 | Sell |
| 20-day EMA: | 21.4 | Sell |
| 50-day EMA: | 22.83 | Sell |
| 200-day EMA: | 27.29 | Sell |
Fossil Group Earnings Growth & FOSL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Fossil Group Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||